Table 1 of
Scheive, Mol Vis 2022; 28:220-229. Table 1 of
Scheive, Mol Vis 2022; 28:220-229.
Table 1. Demographic information on DR patients included in cross-sectional and longitudinal analysis.
| Demographic Variable | Cross-Sectional | Longitudinal |
|---|---|---|
| OCT-A scans, n | 151 | 149 |
| Patients, n | 93 | 36 |
| Eyes, n | 151 | 51 |
| OD, n (%) | 76 (50.3%) | 24 (47.1%) |
| Mean logMAR of eyes (range) | 0.18 (−0.125- 1.301) | 0.209 (−0.125–1.301) |
| Mean age ± SD, years (range) | 56±13.8 (18–79) | 58±12.5 (22–78) |
| Male, n (%) | 47 (49.5%) | 19 (52.8%) |
| DR diagnosis, n of eyes (%) | ||
| Mild NPDR | 33 scans/eyes (21.9%) | 11 scans (7.4%) 9 scans with anti-VEGF (7.1%) 6 eyes (11.8%) |
| Moderate/severe NPDR | 84 scans/eyes (55.6%) | 97 scans (67.4%) 84 scans with anti-VEGF (76.4%) 31 eyes (60.8%) |
| PDR | 34 scans/eyes (22.5%) | 41 scans (27.5%) 34 scans with anti-VEGF (26.8%) 14 eyes (27.5%) |
| Anti-VEGF, n (%) | 28 scans/eyes (18.5%) | 127 scans (85.2%) 41 eyes (80.4%) |
| Medical history, n (%) | ||
| Cataract surgery | 23 eyes (15.2%) | 8 eyes (15.7%) |
| Glaucoma | 20 eyes (13.2%) | 8 eyes (15.7%) |
| Hypertension | 87 patients (93.5%) | 33 patients (91.7%) |
| Sleep apnea | 15 patients (16.1%) | 10 patients (27.8%) |
| Race, n (%) | ||
| African American | 43 (46%) | 15 (41.7%) |
| Asian | 2 (2.2%) | 2 (5.6%) |
| Native Hawaiians and Other Pacific Islanders | 2 (2.2%) | 0 (0%) |
| White | 46 (49%) | 19 (52.8%) |